Hello! I am seeking to raise $4,000 in the name of equitable healthcare for all.

I have recently applied myself, and in turn my company (Clinically Media), into two competitive development programs. I have recently learned that we have been accepted into both! After 4 years of hard work, this is incredibly exciting. These programs are game changers for the trajectory of Clinically Media as we work towards our mission of bringing clinical research to the forefront of medical treatment plans, while simultaneously improving the much-needed diversity of patient data collected during clinical trials.

Program 1: Colorado Bioscience Executive Leadership, 2023 Cohort

After applying twice, I have finally been accepted! The program includes five interactive modules over seven months including an emphasis on peer-to-peer networks, executive coaching, and mentoring to drive action and accountability. The program will launch in February 2023. Cost is $5,000. I have received a $2,500 scholarship, the maximum amount awarded.

Program 2: FocalPoint Life Sciences Leadership Program, Q1 2023 Program

This 3-month program includes an emphasis on cultivating entrepreneurial success through implementing strategic business decisions, improving productivity, and assessing financial goal setting through behavioral analysis. The program will launch in January 2023. Cost is $1,500. No scholarship options are available.

As Clinically Media marches heavily towards improving healthcare for all, we have made the decision to invest all profit back into Clinically Media. Thus, funding participation in these programs (that WILL get us closer to completing our mission) is simply out of budget right now, especially so early in the year.

I am asking for financial contributions so we can continue our work to improve access to lifesaving treatments as soon as possible.

Please view any contribution you are able to make to this fund as a contribution to a more equitable healthcare system – a healthcare system that brings high-quality medical care to those who need it, that is representative of all people, and that brings life-saving medical treatments to market faster.